Cellid signs Covid-19 vaccine research contract with IVI
Cellid and the International Vaccine Institute (IVI) have signed a research service contract to collaborate...
Bridge Biotherapeutics terminates collaboration agreement with Boehringer
Bridge Biotherapeutics and Boehringer Ingelheim have mutually agreed to terminate their previously signed collaboration and...
Humanigen to enter Asia-Pacific market with Covid-19 drug
Humanigen has executed a licensing agreement with Telcon RF Pharmaceutical and KPM Tech for development...
Samsung Biologics’ P4 Super Plant, Songdo
Samsung Biologics is planning to expand its manufacturing facilities with the construction of its fourth...
Eisai and Seikagaku partner for osteoarthritis drug in South Korea
Japanese pharmaceutical company Eisai has signed a marketing alliance agreement with Seikagaku for SI-613 (diclofenac...
Samsung Biologics signs $330m deal to produce AstraZeneca’s therapies
South Korea-based biopharmaceutical services provider Samsung Biologics has signed a long-term supply agreement, valued at...
SK bioscience partners with Novavax on Covid-19 vaccine
South Korea-based SK bioscience has entered into a development and supply agreement for Novavax Covid-19...
Samsung Biologics to build fourth manufacturing plant
South Korea-based biomedicine maker Samsung Biologics has unveiled plans to build its fourth plant this...
Daewoong finds niclosamide effective against Covid-19 in animal tests
South Korea-based Daewoong Pharmaceutical has found that its anti-parasitic drug niclosamide had removed SARS-CoV-2, the...